Nasdaq · Healthcare
Omada Health, Inc. (OMDA)
As-reported financials and recent SEC filings for Omada Health, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$260.2M
Net income
$-12.8M
Net margin
-4.9%
Diluted EPS
$-0.35
ROE
-5.6%
P/E (TTM)
—
Market cap
$1.24B
Debt / equity
0.0×
Income statement (as reported)
| Line | FY2025 | FY2025 | FY2025 |
|---|---|---|---|
| Revenue | $260.2M | $169.8M | $122.8M |
| Gross profit | $170.9M | $102.9M | $70.0M |
| Operating income | $-12.0M | $-43.7M | $-66.0M |
| Net income | $-12.8M | $-47.1M | $-67.5M |
| Diluted EPS | $-0.35 | $-1.22 | $-1.90 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
1442026-06-26
View on EDGAR →1442026-06-26
View on EDGAR →1442026-06-26
View on EDGAR →42026-06-26
View on EDGAR →42026-06-26
View on EDGAR →42026-06-26
View on EDGAR →1442026-06-25
View on EDGAR →1442026-06-25
View on EDGAR →Go deeper on OMDA
Search Omada Health, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.